HighPoint Advisor Group’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,749
Closed -$428K 702
2025
Q2
$428K Buy
1,749
+10
+0.6% +$2.49K 0.02% 415
2025
Q1
$451K Buy
1,739
+230
+15% +$62.2K 0.03% 383
2024
Q4
$388K Buy
1,509
+87
+6% +$23.3K 0.02% 435
2024
Q3
$371K Buy
1,422
+128
+10% +$45.6K 0.02% 430
2024
Q2
$523K Sell
1,294
-94
-7% -$31.7K 0.03% 339
2024
Q1
$471K Buy
1,388
+389
+39% +$147K 0.03% 358
2023
Q4
$347K Buy
+999
New +$492K 0.02% 433
2022
Q2
$216K Buy
+453
New +$202K 0.02% 478
2021
Q3
Sell
-480
Closed -$213K 582
2021
Q2
$213K Buy
+480
New +$210K 0.02% 489
2019
Q4
Sell
-467
Closed -$148K 414
2019
Q3
$148K Buy
467
+80
+21% +$22.4K 0.03% 368
2019
Q2
$109K Buy
+387
New +$98.1K 0.03% 436

Other funds holding HUM

HighPoint Advisor Group's HUM Position: Q3 2025 in Review

HighPoint Advisor Group sold out of Humana (HUM) in Q3 2025, closing a stake of 1,749 shares — an estimated $428K sold.

HighPoint Advisor Group first reported a position in HUM in Q2 2019 and held it in 11 quarters. The position peaked at $523K in Q2 2024. 892 funds tracked by Wall St. Rank hold HUM as of Q3 2025.

  • HighPoint Advisor Group reported no remaining Humana position as of Q3 2025 after selling out during the quarter.
  • HighPoint Advisor Group sold 1,749 Humana shares in Q3 2025, an estimated $428K.
  • HighPoint Advisor Group first reported a position in Humana in Q2 2019 and held it in 11 quarters.
  • HighPoint Advisor Group's Humana position peaked at $523K in Q2 2024.
  • 892 funds tracked by Wall St. Rank held Humana as of Q3 2025.

Based on HighPoint Advisor Group's 13F filing for Q3 2025, filed 5 Nov 2025.